Controversial new research suggests that doping with recombinant human erythropoietin (EPO) – a behaviour that has brought down many elite cyclists – may not enhance racing performance. The Dutch study published in Lancet Haematology found EPO provided a small benefit in terms of maximal performance in the laboratory that did not translate into an advantage in a real-life cycling ...
EPO gives no edge to serious cyclists, researchers say
By Mardi Chapman
6 Jul 2017